Cellosaurus Index : CVCL_4613
Cellosaurus ID : BDCM
CCLE Name
: BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
CTRP2 Name
: BDCM
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Click to show/hide information cards below or download all drug response information.
 Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
---|---|---|---|---|---|
BDCM | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | AEW541 | CCLE | 0.0025 | 8.0000 | |
BDCM | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
BDCM | austocystin D | CTRP2 | 0.0011 | 37.0000 | |
BDCM | AZD6482 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | AZD7762 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | AZD8055 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | BIX-01294 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | BMS-536924 | CTRP2 | 0.0011 | 37.0000 | |
BDCM | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
BDCM | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 | |
BDCM | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 | |
BDCM | BRD4132 | CTRP2 | 0.0097 | 160.0000 | |
BDCM | BRD6340 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | C6-ceramide | CTRP2 | 0.0020 | 66.0000 | |
BDCM | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
BDCM | CAY10618 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | cerulenin | CTRP2 | 0.0045 | 150.0000 | |
BDCM | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 | |
BDCM | ciclopirox | CTRP2 | 0.0020 | 66.0000 | |
BDCM | ciclosporin | CTRP2 | 0.0010 | 33.0000 | |
BDCM | Crizotinib | CCLE | 0.0025 | 8.0000 | |
BDCM | DBeQ | CTRP2 | 0.0020 | 66.0000 | |
BDCM | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
BDCM | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
BDCM | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
BDCM | Erlotinib | CCLE | 0.0025 | 8.0000 | |
BDCM | Etoposide | CTRP2 | 0.0009 | 28.0000 | |
BDCM | Foretinib | CTRP2 | 0.0020 | 66.0000 | |
BDCM | FQI-2 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 | |
BDCM | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 | |
BDCM | GSK4112 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | GW-405833 | CTRP2 | 0.0041 | 130.0000 | |
BDCM | I-BET151 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 | |
BDCM | KU-0063794 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | KW-2449 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 | |
BDCM | Lapatinib | CCLE | 0.0025 | 8.0000 | |
BDCM | LBW242 | CCLE | 0.0025 | 8.0000 | |
BDCM | leptomycin B | CTRP2 | 0.0020 | 66.0000 | |
BDCM | lomeguatrib | CTRP2 | 0.0020 | 66.0000 | |
BDCM | MI-1 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | MLN2238 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
BDCM | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
BDCM | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
BDCM | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
BDCM | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
BDCM | neratinib | CTRP2 | 0.0010 | 33.0000 | |
BDCM | Nilotinib | CCLE | 0.0025 | 8.0000 | |
BDCM | nintedanib | CTRP2 | 0.0020 | 66.0000 | |
BDCM | NPC-26 | CTRP2 | 0.0012 | 40.0000 | |
BDCM | Nutlin-3a | CCLE | 0.0025 | 8.0000 | |
BDCM | NVP-TAE684 | CCLE | 0.0025 | 8.0000 | |
BDCM | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 | |
BDCM | ouabain | CTRP2 | 0.0081 | 270.0000 | |
BDCM | PAC-1 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | Paclitaxel | CCLE | 0.0025 | 8.0000 | |
BDCM | Palbociclib | CCLE | 0.0025 | 8.0000 | |
BDCM | Panobinostat | CCLE | 0.0025 | 8.0000 | |
BDCM | PD0325901 | CCLE | 0.0025 | 8.0000 | |
BDCM | PHA-665752 | CCLE | 0.0025 | 8.0000 | |
BDCM | pluripotin | CTRP2 | 0.0010 | 33.0000 | |
BDCM | PLX-4720 | CCLE | 0.0025 | 8.0000 | |
BDCM | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 | |
BDCM | RAF265 | CCLE | 0.0025 | 8.0000 | |
BDCM | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 | |
BDCM | Saracatinib | CCLE | 0.0025 | 8.0000 | |
BDCM | SB-743921 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | Selumetinib | CCLE | 0.0025 | 8.0000 | |
BDCM | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
BDCM | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
BDCM | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
BDCM | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 | |
BDCM | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 | |
BDCM | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 | |
BDCM | semagacestat | CTRP2 | 0.0020 | 66.0000 | |
BDCM | SGX-523 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 | |
BDCM | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 | |
BDCM | SU11274 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | Sunitinib | CTRP2 | 0.0020 | 66.0000 | |
BDCM | Tanespimycin | CTRP2,CCLE | 0.0010 | 33.0000 | |
BDCM | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 | |
BDCM | TKI258 | CCLE | 0.0025 | 8.0000 | |
BDCM | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 | |
BDCM | TW 37 | CTRP2 | 0.0010 | 33.0000 | |
BDCM | vandetanib | CTRP2 | 0.0020 | 66.0000 | |
BDCM | Veliparib | CTRP2 | 0.0010 | 33.0000 | |
BDCM | VU0155056 | CTRP2 | 0.0020 | 66.0000 | |
BDCM | ZD-6474 | CCLE | 0.0025 | 8.0000 |